Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
Journal of Biotechnology|January 26, 1996
Induction of antibodies against SIV antigens after intramuscular nucleic acid inoculation using complex expression constructsS Wagener, S Norley, J zur Megede, et al.Developments in Biological Standardization|January 1, 1991
Epidemiology and pathogenicity of human retrovirusesR Kurth, M Baier, D Binninger, et al.Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Vaccine protection against SIVmac infection by high- but not low-dose whole inactivated virus immunogenS Hartung, S G Norley, J Ennen, et al.Nature Biotechnology|June 3, 2000
Spleen necrosis virus-derived C-type retroviral vectors for gene transfer to quiescent cellsZ Parveen, A Krupetsky, M Engelstädter, et al.Gene Therapy|May 30, 2008
Cell entry targeting restricts biodistribution of replication-competent retroviruses to tumour tissueL J Duerner, A Schwantes, I C Schneider, et al.Proceedings of the National Academy of Sciences of the United States of America|August 15, 1992
Development of a quasispecies of human immunodeficiency virus type 1 in vivoK Cichutek, H Merget, S Norley, et al.Virology|July 13, 2000
Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1J Stitz, C J Buchholz, M Engelstädter, et al.Gene Therapy|April 8, 2011
RNAi-mediated gene silencing in tumour tissue using replication-competent retroviral vectorsT Schaser, C Wrede, L Duerner, et al.AIDS (London, England)|October 1, 1991
Lack of HIV-1 V3 region sequence diversity in two haemophiliac patients infected with a putative biologic clone of HIV-1K Cichutek, S Norley, R Linde, et al.Journal of Virology|April 3, 1998
The U3 promoter and the nef gene of simian immunodeficiency virus (SIV) smmPBj1.9 do not confer acute pathogenicity upon SIVagmS Wagener, M T Dittmar, B Beer, et al.Pageof 5